Literature DB >> 580695

Ocular neovascularization. The Krill memorial lecture.

P Henkind.   

Abstract

The various vascular systems of the eye can undergo new vessel formation. In this presentation, I discuss new vessel growth in the cornea, lens, iris, ciliary body, choroid, retina, and optic nerve head. No single factor can explain all cases of ocular neovascularization; instead there are multiple factors which can affect the various susceptible vessels. Among the known vasculognic factors are: inflammation and its products, a hypoxic retina diffusable factor, the "tumor angiogenic factor," and possibly an aging factor. The different ocular beds possess differing sensitivity to the various vasculogenic stimuli; the iris and choroid being most sensitive and the retina and ciliary body least sensitive to such stimuli. Retinal neovascularization requires both a biochemical factor and a diseased retinal vascular bed for its induction. Ocular neovascularization is a dynamic process which requires a persisting stimulus or else the new vessels tend to regress. The normal eye seems to possess at least two antivasculogenic agents.

Entities:  

Mesh:

Year:  1978        PMID: 580695

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  41 in total

Review 1.  Birdshot retinochoroidopathy.

Authors:  A T Gasch; J A Smith; S M Whitcup
Journal:  Br J Ophthalmol       Date:  1999-02       Impact factor: 4.638

Review 2.  Role of vascular permeability factor/vascular endothelial growth factor in eye disease.

Authors:  R O Schlingemann; V W van Hinsbergh
Journal:  Br J Ophthalmol       Date:  1997-06       Impact factor: 4.638

3.  Post traumatic neovascularisation of a cataractous crystalline lens.

Authors:  Sagarika Patyal; Sunita Kakkar; V S Gurunadh; P G Pradeep
Journal:  Med J Armed Forces India       Date:  2014-11-25

4.  Ophthalmology-epitomes of progress: diabetic retinopathy.

Authors:  R R Peabody
Journal:  West J Med       Date:  1981-08

5.  A model of growing vascular structures.

Authors:  F Nekka; S Kyriacos; C Kerrigan; L Cartilier
Journal:  Bull Math Biol       Date:  1996-05       Impact factor: 1.758

6.  Experimental studies on the angiogenic activity of the detached retina.

Authors:  M Prost
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1990       Impact factor: 3.117

7.  Clinical Management of Recurrent Retinopathy of Prematurity after Intravitreal Bevacizumab Monotherapy.

Authors:  Helen A Mintz-Hittner; Megan M Geloneck; Alice Z Chuang
Journal:  Ophthalmology       Date:  2016-05-27       Impact factor: 12.079

8.  Subretinal neovascularisation and snow banking in a case of sarcoidosis: case report.

Authors:  V Pellegrini; S Ohno; S Hirose; H Matsuda; Y Hiraga
Journal:  Br J Ophthalmol       Date:  1986-06       Impact factor: 4.638

9.  Anticancer Role of PPARgamma Agonists in Hematological Malignancies Found in the Vasculature, Marrow, and Eyes.

Authors:  P J Simpson-Haidaris; S J Pollock; S Ramon; N Guo; C F Woeller; S E Feldon; R P Phipps
Journal:  PPAR Res       Date:  2010-02-28       Impact factor: 4.964

10.  Fundus changes in histologically confirmed sarcoidosis.

Authors:  D J Spalton; M D Sanders
Journal:  Br J Ophthalmol       Date:  1981-05       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.